Free Trial

Canopy Growth (WEED) Competitors

Canopy Growth logo
C$1.76 +0.01 (+0.57%)
As of 07/4/2025 04:00 PM Eastern

WEED vs. CMED, EMC, OGI, ICC, LEAF, MGW, BE, BLO, SL, and MJN

Should you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include CanniMed Therapeutics (CMED), Emblem (EMC), Organigram (OGI), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry.

Canopy Growth vs. Its Competitors

Canopy Growth (TSE:WEED) and CanniMed Therapeutics (TSE:CMED) are both small-cap cannabis companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

CanniMed Therapeutics has a net margin of 0.00% compared to Canopy Growth's net margin of -201.27%. CanniMed Therapeutics' return on equity of 0.00% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Canopy Growth-201.27% -108.18% -3.83%
CanniMed Therapeutics N/A N/A N/A

9.4% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Canopy Growth currently has a consensus target price of C$2.20, suggesting a potential upside of 25.00%. Given Canopy Growth's stronger consensus rating and higher probable upside, research analysts plainly believe Canopy Growth is more favorable than CanniMed Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth
3 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
CanniMed Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Canopy Growth had 3 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 3 mentions for Canopy Growth and 0 mentions for CanniMed Therapeutics. Canopy Growth's average media sentiment score of 0.21 beat CanniMed Therapeutics' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company Overall Sentiment
Canopy Growth Neutral
CanniMed Therapeutics Neutral

CanniMed Therapeutics has lower revenue, but higher earnings than Canopy Growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Canopy GrowthC$519.68M0.54-C$1.05B-C$6.85-0.26
CanniMed TherapeuticsN/AN/AN/AN/AN/A

Summary

Canopy Growth beats CanniMed Therapeutics on 7 of the 10 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WEED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WEED vs. The Competition

MetricCanopy GrowthDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$283.13MC$2.13BC$5.56BC$6.19B
Dividend Yield4.80%2.92%5.22%6.72%
P/E Ratio-0.264.1827.6650.85
Price / Sales0.54566.59423.001,194.54
Price / Cash1.6310.3536.8983.29
Price / Book0.3011.628.034.69
Net Income-C$1.05BC$21.15BC$3.18BC$301.20M
7 Day Performance4.14%1.82%2.93%2.29%
1 Month Performance-23.81%6.41%1.72%4.22%
1 Year Performance-79.63%2.54%34.39%26.95%

Canopy Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WEED
Canopy Growth
0.7155 of 5 stars
C$1.76
+0.6%
C$2.20
+25.0%
-79.6%C$283.13MC$519.68M-0.262,700News Coverage
CMED
CanniMed Therapeutics
N/AN/AN/AN/AC$668.44MN/A0.00147,000
EMC
Emblem
N/A$1.88
+1.6%
N/A+0.0%$245.45M$5.71M-9.89N/A
OGI
Organigram
3.2467 of 5 stars
C$1.84
flat
C$3.33
+80.7%
-12.0%C$227.32MC$180.58M-3.89987News Coverage
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150News Coverage
MGW
Maple Leaf Green World
N/AC$0.79
+777.8%
N/A+0.0%C$111.69MN/A0.00N/AGap Up
BE
Beleave
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
BLO
Cannabix Technologies
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Down
SL
Supreme Cannabis Company Inc,
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Down
High Trading Volume
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/A0.007,600

Related Companies and Tools


This page (TSE:WEED) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners